Gilead Sciences Inc. (GILD)

Index:

Nasdaq 100

$ 156.77
   
  • Change Today:
    $4.96
  • 52 Week High: $156.95
  • 52 Week Low: $97.07
  • Currency: US Dollars
  • Shares Issued: 1,246.00m
  • Volume: 3,499,150
  • Market Cap: $195,335m
  • RiskGrade: 120

Latest ShareCast News

GSK's ViiV says trial indicates HIV shot as effective as rival Gilead pill

By Frank Prenesti

Date: Thursday 23 Feb 2023

(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GILD Market Data

Currency US Dollars
Share Price $ 156.77
Change Today $ 4.96
% Change 3.27 %
52 Week High $156.95
52 Week Low $97.07
Volume 3,499,150
Shares Issued 1,246.00m
Market Cap $195,335m
RiskGrade 120

What The Brokers Say

Strong Buy 10
Buy 13
Neutral 5
Sell 1
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 13-Feb-2026

Time Volume / Share Price
14:46 1,099 @ $156.77
14:46 100 @ $156.79
14:46 100 @ $156.76
14:46 162 @ $156.78
14:46 100 @ $156.81

Top of Page